NasdaqCM - Nasdaq Real Time Price USD
Windtree Therapeutics, Inc. (WINT)
As of 11:23 AM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
25,506.0000
17,539.0000
21,889.0000
32,260.0000
30,317.0000
Operating Income
-25,506.0000
-17,539.0000
-21,889.0000
-32,260.0000
-30,317.0000
Net Non Operating Interest Income Expense
75.0000
275.0000
56.0000
-23.0000
-3.0000
Other Income Expense
14,358.0000
-3,027.0000
-18,742.0000
-45,340.0000
-2,246.0000
Pretax Income
-11,073.0000
-20,291.0000
-40,575.0000
-77,623.0000
-32,566.0000
Tax Provision
311.0000
--
-1,367.0000
-9,987.0000
--
Net Income Common Stockholders
-11,384.0000
-20,291.0000
-39,208.0000
-67,636.0000
-32,566.0000
Diluted NI Available to Com Stockholders
-11,384.0000
-20,291.0000
-39,208.0000
-67,636.0000
-32,566.0000
Basic EPS
-19.03
-94.32
-1.12k
-2.46k
-1.87k
Diluted EPS
-19.03
-94.32
-1.12k
-2.46k
-1.87k
Basic Average Shares
407.3330
215.3330
35.0000
27.5110
17.3930
Diluted Average Shares
407.3330
215.3330
35.0000
27.5110
17.3930
Total Operating Income as Reported
-25,506.0000
-20,597.0000
-41,333.0000
-77,280.0000
-30,317.0000
Total Expenses
25,506.0000
17,539.0000
21,889.0000
32,260.0000
30,317.0000
Net Income from Continuing & Discontinued Operation
-11,384.0000
-20,291.0000
-39,208.0000
-67,636.0000
-32,566.0000
Normalized Income
-22,854.8000
-17,233.0000
-21,095.4984
-28,408.2876
-32,566.0000
Interest Income
223.0000
325.0000
109.0000
91.0000
122.0000
Interest Expense
148.0000
50.0000
53.0000
114.0000
125.0000
Net Interest Income
75.0000
275.0000
56.0000
-23.0000
-3.0000
EBIT
-10,925.0000
-20,241.0000
-40,522.0000
-77,509.0000
-32,441.0000
EBITDA
-10,852.0000
-20,159.0000
-39,989.0000
-77,317.0000
-32,273.0000
Reconciled Depreciation
73.0000
82.0000
533.0000
192.0000
168.0000
Net Income from Continuing Operation Net Minority Interest
-11,384.0000
-20,291.0000
-39,208.0000
-67,636.0000
-32,566.0000
Total Unusual Items Excluding Goodwill
14,520.0000
-3,058.0000
-18,744.0000
-45,020.0000
--
Total Unusual Items
14,520.0000
-3,058.0000
-18,744.0000
-45,020.0000
--
Normalized EBITDA
-25,372.0000
-17,101.0000
-21,245.0000
-32,297.0000
-32,273.0000
Tax Rate for Calcs
0.0002
--
0.0000
0.0001
--
Tax Effect of Unusual Items
3,049.2000
--
-631.4984
-5,792.2876
--
12/31/2020 - 8/7/1995
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ADTX Aditxt, Inc.
0.5271
-5.03%
GRI GRI Bio, Inc.
1.0800
+23.01%
TFFP TFF Pharmaceuticals, Inc.
2.4000
-4.00%
QLGN Qualigen Therapeutics, Inc.
0.1002
+1.62%
TCBP TC Biopharm (Holdings) Plc
1.3599
+3.02%
ALLR Allarity Therapeutics, Inc.
1.3931
-0.49%
PLRZ Polyrizon Ltd.
1.2300
-10.87%
CNSP CNS Pharmaceuticals, Inc.
0.1171
+4.93%
LIXT Lixte Biotechnology Holdings, Inc.
2.0800
-1.42%
SLXN Silexion Therapeutics Corp
0.2742
-5.42%